Solara Active Pharma Sciences Limited SOLARA.NS Stock
Solara Active Pharma Sciences Limited Price Chart
Solara Active Pharma Sciences Limited SOLARA.NS Financial and Trading Overview
| Solara Active Pharma Sciences Limited stock price | 429.1 INR |
| Previous Close | 376.05 INR |
| Open | 379.7 INR |
| Bid | 381.05 INR x 0 |
| Ask | 381.7 INR x 0 |
| Day's Range | 378.5 - 389.95 INR |
| 52 Week Range | 320 - 495 INR |
| Volume | 216.72K INR |
| Avg. Volume | 148.88K INR |
| Market Cap | 13.72B INR |
| Beta (5Y Monthly) | 0.55264 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -78.93 INR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 18, 2021 |
| 1y Target Est | 447.25 INR |
SOLARA.NS Valuation Measures
| Enterprise Value | 23.56B INR |
| Trailing P/E | N/A |
| Forward P/E | 13.554409 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.9502628 |
| Price/Book (mrq) | 0.91220653 |
| Enterprise Value/Revenue | 1.632 |
| Enterprise Value/EBITDA | 17.597 |
Trading Information
Solara Active Pharma Sciences Limited Stock Price History
| Beta (5Y Monthly) | 0.55264 |
| 52-Week Change | 7.30% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 495 INR |
| 52 Week Low | 320 INR |
| 50-Day Moving Average | 365.77 INR |
| 200-Day Moving Average | 402.41 INR |
SOLARA.NS Share Statistics
| Avg. Volume (3 month) | 148.88K INR |
| Avg. Daily Volume (10-Days) | 218.49K INR |
| Shares Outstanding | 36M |
| Float | 14.56M |
| Short Ratio | N/A |
| % Held by Insiders | 60.42% |
| % Held by Institutions | 19.46% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -1.53% |
| Operating Margin (ttm) | 1.57% |
| Gross Margin | 45.36% |
| EBITDA Margin | 9.27% |
Management Effectiveness
| Return on Assets (ttm) | 0.48% |
| Return on Equity (ttm) | -1.46% |
Income Statement
| Revenue (ttm) | 14.44B INR |
| Revenue Per Share (ttm) | 401.17 INR |
| Quarterly Revenue Growth (yoy) | 5.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | 1.34B INR |
| Net Income Avi to Common (ttm) | -221700000 INR |
| Diluted EPS (ttm) | -6.54 |
| Quarterly Earnings Growth (yoy) | 100.49% |
Balance Sheet
| Total Cash (mrq) | 88.9M INR |
| Total Cash Per Share (mrq) | 2.48 INR |
| Total Debt (mrq) | 10.13B INR |
| Total Debt/Equity (mrq) | 67.41 INR |
| Current Ratio (mrq) | 1.078 |
| Book Value Per Share (mrq) | 417.833 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.56B INR |
| Levered Free Cash Flow (ttm) | -207400000 INR |
Profile of Solara Active Pharma Sciences Limited
| Country | India |
| State | N/A |
| City | Chennai |
| Address | Admin Block 27 |
| ZIP | 600127 |
| Phone | 91 44 4344 6700 |
| Website | https://www.solara.co.in |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India. The company offers APIs for anesthetics, anthelmintic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-viral, antibiotic, anticoagulant, anticonvulsant, antidepressant, antiemetic, antiepileptic, antifungal, antigout agent, antihistamine, antihyperlipoproteinemic, antimalarial, antimycotic, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antitussive, antiulcerative, anxiolytic, bile acid analogue, calcimimetic agent, cardiovascular agent, central nervous system agent, chronic alcoholism, chronic kidney disease, dopamine receptor antagonist, folate analog, hyperkalaemia, immunosuppressant, lipid regulating agent, loop diuretic, muscarinic agonist, neuromuscular, OAB treatment, phenylalanine reducer, recovery of stroke, tardive dyskinesia, treatment of glaucoma and hyperphosphatemia, tropical anti-infective, and type-II diabetes therapeutic categories. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical services, impurity synthesis, and regulatory support. In addition, the company exports its products. It operates in the Asia Pacific, Europe, North America, South America, and internationally. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India.
Q&A For Solara Active Pharma Sciences Limited Stock
What is a current SOLARA.NS stock price?
Solara Active Pharma Sciences Limited SOLARA.NS stock price today per share is 429.1 INR.
How to purchase Solara Active Pharma Sciences Limited stock?
You can buy SOLARA.NS shares on the NSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Solara Active Pharma Sciences Limited?
The stock symbol or ticker of Solara Active Pharma Sciences Limited is SOLARA.NS.
Which industry does the Solara Active Pharma Sciences Limited company belong to?
The Solara Active Pharma Sciences Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Solara Active Pharma Sciences Limited have in circulation?
The max supply of Solara Active Pharma Sciences Limited shares is 39.06M.
What is Solara Active Pharma Sciences Limited Price to Earnings Ratio (PE Ratio)?
Solara Active Pharma Sciences Limited PE Ratio is now.
What was Solara Active Pharma Sciences Limited earnings per share over the trailing 12 months (TTM)?
Solara Active Pharma Sciences Limited EPS is -78.93 INR over the trailing 12 months.
Which sector does the Solara Active Pharma Sciences Limited company belong to?
The Solara Active Pharma Sciences Limited sector is Healthcare.